NCT00551239 2020-10-19Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaCTI BioPharmaPhase 3 Withdrawn
NCT00608374 2013-08-26Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic LymphomaNational Cancer Institute (NCI)Phase 3 Completed400 enrolled